2022 Q2 Form 10-Q Financial Statement

#000117494722000620 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $166.6M $184.4M
YoY Change -9.66% 41.54%
Cost Of Revenue $108.5M $111.8M
YoY Change -2.99% 23.99%
Gross Profit $58.11M $72.57M
YoY Change -19.92% 81.03%
Gross Profit Margin 34.88% 39.36%
Selling, General & Admin $19.38M $20.61M
YoY Change -5.96% 28.34%
% of Gross Profit 33.35% 28.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.755M $7.501M
YoY Change -9.95% 4.18%
% of Gross Profit 11.62% 10.34%
Operating Expenses $19.38M $20.61M
YoY Change -5.96% 28.34%
Operating Profit $38.73M $51.96M
YoY Change -25.46% 116.25%
Interest Expense -$91.00K -$25.00K
YoY Change 264.0% -7.41%
% of Operating Profit -0.23% -0.05%
Other Income/Expense, Net $792.0K $434.0K
YoY Change 82.49% -35.51%
Pretax Income $39.52M $52.39M
YoY Change -24.57% 112.11%
Income Tax $9.287M $14.20M
% Of Pretax Income 23.5% 27.1%
Net Earnings $30.23M $38.19M
YoY Change -20.84% 105.4%
Net Earnings / Revenue 18.15% 20.71%
Basic Earnings Per Share $1.72 $2.18
Diluted Earnings Per Share $1.70 $2.16
COMMON SHARES
Basic Shares Outstanding 17.61M shares 17.56M shares
Diluted Shares Outstanding 17.81M shares 17.72M shares

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $211.6M $146.1M
YoY Change 44.82% -35.53%
Cash & Equivalents $41.59M $24.14M
Short-Term Investments $170.0M $122.0M
Other Short-Term Assets $8.416M $4.200M
YoY Change 100.38% 61.54%
Inventory $46.91M $28.75M
Prepaid Expenses
Receivables $69.35M $73.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $336.3M $252.2M
YoY Change 33.33% -14.48%
LONG-TERM ASSETS
Property, Plant & Equipment $80.72M $70.80M
YoY Change 14.02% 4.27%
Goodwill $3.264M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.50M $41.00M
YoY Change -28.05% 51.85%
Total Long-Term Assets $110.2M $111.9M
YoY Change -1.52% 17.87%
TOTAL ASSETS
Total Short-Term Assets $336.3M $252.2M
Total Long-Term Assets $110.2M $111.9M
Total Assets $446.5M $364.1M
YoY Change 22.62% -6.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.53M $34.50M
YoY Change -2.82% -13.1%
Accrued Expenses $26.91M $28.30M
YoY Change -4.91% 6.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $66.18M $73.00M
YoY Change -9.35% -4.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.348M $1.700M
YoY Change 38.12% -15.0%
Total Long-Term Liabilities $2.348M $1.700M
YoY Change 38.12% -15.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.18M $73.00M
Total Long-Term Liabilities $2.348M $1.700M
Total Liabilities $68.53M $75.60M
YoY Change -9.36% -3.45%
SHAREHOLDERS EQUITY
Retained Earnings $452.9M $367.8M
YoY Change 23.12%
Common Stock $46.33M $41.96M
YoY Change 10.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $145.6M $145.6M
YoY Change 0.0%
Treasury Stock Shares 6.710M shares 6.710M shares
Shareholders Equity $378.0M $288.5M
YoY Change
Total Liabilities & Shareholders Equity $446.5M $364.1M
YoY Change 22.62% -6.61%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income $30.23M $38.19M
YoY Change -20.84% 105.4%
Depreciation, Depletion And Amortization $6.755M $7.501M
YoY Change -9.95% 4.18%
Cash From Operating Activities $18.76M $27.77M
YoY Change -32.44% -40.91%
INVESTING ACTIVITIES
Capital Expenditures $10.88M $5.516M
YoY Change 97.26% -406.44%
Acquisitions
YoY Change
Other Investing Activities $29.98M -$1.000M
YoY Change -3098.1% -98.31%
Cash From Investing Activities $19.10M -$6.495M
YoY Change -394.07% -89.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$17.32M -$17.29M
YoY Change 0.2% 174.37%
NET CHANGE
Cash From Operating Activities $18.76M $27.77M
Cash From Investing Activities $19.10M -$6.495M
Cash From Financing Activities -$17.32M -$17.29M
Net Change In Cash $20.54M $3.990M
YoY Change 414.84% -119.56%
FREE CASH FLOW
Cash From Operating Activities $18.76M $27.77M
Capital Expenditures $10.88M $5.516M
Free Cash Flow $7.880M $22.25M
YoY Change -64.59% -54.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000095029
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
852000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
451000 USD
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
792000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
434000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39519000 USD
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5237000 USD
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
USD
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
66177000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77109000 USD
CY2022Q2 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
100000 USD
CY2021Q4 rgr Product Liability Accrual Noncurrent
ProductLiabilityAccrualNoncurrent
97000 USD
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2248000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1476000 USD
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46328000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
46847000 USD
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
452872000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
438098000 USD
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
6709898 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6709898 shares
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
145590000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
145590000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
377953000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
363661000 USD
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446478000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
442343000 USD
CY2022Q2 us-gaap Revenues
Revenues
166575000 USD
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108467000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111811000 USD
CY2022Q2 us-gaap Gross Profit
GrossProfit
58108000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
72566000 USD
CY2022Q2 us-gaap Selling Expense
SellingExpense
8435000 USD
CY2021Q2 us-gaap Selling Expense
SellingExpense
8088000 USD
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10946000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12522000 USD
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
19381000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
20610000 USD
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
38727000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
51956000 USD
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000 USD
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-91000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-25000 USD
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2154000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9287000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14198000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
30232000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
38192000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52390000 USD
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.72
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.18
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
30232000 USD
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.16
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17610202 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17559624 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17806457 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17718481 shares
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.86
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
363661000 USD
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
15165000 USD
CY2022Q2 us-gaap Dividends Paidinkind
DividendsPaidinkind
293000 USD
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1672000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
377953000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
30232000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
38192000 USD
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6755000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7501000 USD
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1672000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3381000 USD
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000 USD
CY2021Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
11000 USD
CY2022Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
443000 USD
CY2021Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
2406000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12311000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15289000 USD
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3064000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-323000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2232000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1836000 USD
CY2022Q2 rgr Contract Liability To Customers
ContractLiabilityToCustomers
USD
CY2021Q2 rgr Contract Liability To Customers
ContractLiabilityToCustomers
-84000 USD
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13840000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16495000 USD
CY2022Q2 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-289000 USD
CY2021Q2 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-108000 USD
CY2022Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6163000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-530000 USD
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5237000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9260000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18761000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27770000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10881000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5516000 USD
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2021Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000 USD
CY2022Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
29992000 USD
CY2021Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
146992000 USD
CY2022Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
59973000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
457000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
340000 USD
CY2021Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
146002000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19100000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6495000 USD
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2154000 USD
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4801000 USD
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15165000 USD
CY2021Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12484000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17319000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17285000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20542000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3990000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21044000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20147000 USD
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41586000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24137000 USD
CY2022Q2 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="d1e3191_anchor" style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 1 — BASIS OF PRESENTATION</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended April 2, 2022 may not be indicative of the results to be expected for the full year ending December 31, 2022. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. </p>
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; ">Use of Estimates:</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p>
CY2022Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; ">Reclassifications:</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">Certain prior period balances have been reclassified to conform to current year presentation. </p>
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
84000 USD
CY2022Q2 rgr Revenue Deferred
RevenueDeferred
USD
CY2021Q2 rgr Revenue Deferred
RevenueDeferred
USD
CY2022Q2 rgr Deferred Revenue Recognized
DeferredRevenueRecognized
USD
CY2021Q2 rgr Deferred Revenue Recognized
DeferredRevenueRecognized
-84000 USD
CY2022Q2 us-gaap Deferred Revenue
DeferredRevenue
USD
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
USD
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15677000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7322000 USD
CY2022Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
87824000 USD
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
92701000 USD
CY2022Q2 us-gaap Inventory Gross
InventoryGross
103501000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
100023000 USD
CY2022Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
52674000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
51826000 USD
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3913000 USD
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4347000 USD
CY2022Q2 us-gaap Inventory Net
InventoryNet
46914000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
43850000 USD
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2595000 USD
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2595000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
340000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
454000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
340000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1310000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3241000 USD
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
646000 USD
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2595000 USD
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M24D
CY2022Q2 rgr Line Of Credit Basis Points
LineOfCreditBasisPoints
150
CY2022Q2 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025 pure
CY2022Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000 USD
CY2021Q2 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
1300000 USD
CY2022Q2 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
1300000 USD
CY2022Q2 rgr Estimated Cost For Defined Benefit Plans
EstimatedCostForDefinedBenefitPlans
4000000.0 USD
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2400000 USD
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2400000 USD
CY2022Q2 rgr Defined Benefit Plan Contributions By Employer For Remainder Of Fiscal Year
DefinedBenefitPlanContributionsByEmployerForRemainderOfFiscalYear
5000000.0 USD
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235 pure
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271 pure
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3100000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
200000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
30232000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
38192000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17610202 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17559624 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
196255 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
158857 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17806457 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17718481 shares
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2022Q2 us-gaap Revenues
Revenues
166575000 USD
CY2021Q2 us-gaap Revenues
Revenues
184377000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39519000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52390000 USD
CY2022Q2 us-gaap Depreciation
Depreciation
6388000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
7429000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10881000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5516000 USD
CY2022Q2 us-gaap Assets
Assets
446478000 USD
CY2021Q4 us-gaap Assets
Assets
442343000 USD
CY2022Q2 us-gaap Goodwill
Goodwill
3264000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3264000 USD
CY2022Q2 rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
CY2022Q2 rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2021 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
900000 USD
CY2020 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1100000 USD

Files In Submission

Name View Source Status
0001174947-22-000620-index-headers.html Edgar Link pending
0001174947-22-000620-index.html Edgar Link pending
0001174947-22-000620.txt Edgar Link pending
0001174947-22-000620-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20220402.xsd Edgar Link pending
rgr-20220402_cal.xml Edgar Link unprocessable
rgr-20220402_def.xml Edgar Link unprocessable
rgr-20220402_lab.xml Edgar Link unprocessable
rgr-20220402_pre.xml Edgar Link unprocessable
rgr10q0322.htm Edgar Link pending
rgr10q0322_htm.xml Edgar Link completed
rgr10qex31-1.htm Edgar Link pending
rgr10qex31-2.htm Edgar Link pending
rgr10qex32-1.htm Edgar Link pending
rgr10qex32-2.htm Edgar Link pending
Show.js Edgar Link pending